Description

7-Nitro-3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine is a high-purity, advanced pharmaceutical intermediate characterized by its fused heterocyclic structure. This compound is of significant value in medicinal chemistry for its role as a key synthetic building block in the development of novel active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the synthesis of complex molecules targeting central nervous system and other therapeutic areas. Our supply ensures consistent quality and reliable scalability to support critical R&D and production timelines.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of novel drug candidates, particularly in neurological and psychiatric research.
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• API Development: Used in the process development and scale-up stages for new Active Pharmaceutical Ingredients (APIs).
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process optimization for client projects.
• Academic Research: Utilized in university and institutional labs for studying heterocyclic chemistry and reaction mechanisms.
• Chemical Reference Standard: Can be supplied as a high-purity standard for analytical method development and quality control.

Basic Information

Product Name	7-Nitro-3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine
CAS No.	1260671-19-9
Molecular Formula	C7H7N3O3
Molecular Weight	181.15 g/mol
Synonyms	7-Nitro-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine; 2H-Pyrido[3,2-b][1,4]oxazine, 3,4-dihydro-7-nitro-; 7-Nitro-2H,3H,4H-pyrido[3,2-b][1,4]oxazine; 7-Nitro-3,4-dihydro-2H-pyrido[3,2-b]-1,4-oxazine
EINECS	Contact for details

Quality Control

Every batch of 7-Nitro-3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine undergoes rigorous analytical testing to ensure it meets the stringent requirements for pharmaceutical R&D and manufacturing. Our quality assurance protocols are designed to guarantee high purity, batch-to-batch consistency, and traceability. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment. We adhere to cGMP principles where applicable to support our clients' regulatory submissions.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). The compound may be light-sensitive; prolonged exposure to light should be avoided. Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	Yellow to light brown powder or crystalline solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.